Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 36, 2022 - Issue 15
260
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Lignan derivatives and a jasmonic acid derivative from the seeds of Orychophragmus violaceus

, , &
Pages 3779-3785 | Received 14 Oct 2020, Accepted 02 Feb 2021, Published online: 07 Mar 2021
 

Abstract

A new lignan derivative, 11-deoxykompasinol A (1), together with six known compounds, including five lignan glycosides (2–6) and a jasmonic acid derivative (7), were isolated from the seeds of Orychophragmus violaceus. Structure of the new compound was elucidated on the basis of extensive spectroscopic techniques and ECD (electronic circular dichroism calculations). Since most komasinol derivatives were isolated as racemate, the absolute configuration of this type of compound was reported for the first time. The known compounds were identified by comparison with data reported in the literature. All compounds were tested for their cytotoxic activities against the Hela and HepG2 cell lines in vitro. The new compound 1 exhibited obvious cytotoxicity against the two cell lines with IC50 values of 9.43 and 18.26 μM, respectively. Compounds 2, 5, and 7 were found to possess moderate cytotoxicity against the above cell lines.

Graphical Abstract

Supplementary material

1H and 13C NMR, 1H-1H COSY, HSQC, HMBC, NOESY, HR-ESI-MS and IR spectra of 1 associated with this article are available.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

The authors (G. J. Zhang and J. X. Dong) acknowledge the following agency for funding this project: National Natural Science Foundation of China (81903497).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.